QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. QLT is focused on developing its synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the Company is publicly traded on NASDAQ Stock Market (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT).

QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. QLT is focused on developing its synthetic retinoid program for...Show all

Company (Acquired)

Phone: 877-764-3131

Fax:

887 Great Northern Way
Suite 250
Vancouver, V5T 4T5
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
QLT $0M Jun 15, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related QLT Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension Feb 27, 2013 May 22, 2018 Patent
Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency Apr 19, 2011 Nov 03, 2015 Patent
Sustained release polymer May 22, 2013 Sep 23, 2014 Patent
Sustained release polymer Aug 31, 2006 Jun 25, 2013 Patent
Lacrimal implants and related methods Sep 08, 2008 Dec 18, 2012 Patent
See all 22 patents